Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Life Science seminar 2024

By HC Andersen Capital

Do you want to know more about the latest development in the Nordic Life Science industry? Get an update on HC Andersen Capital's view on valuation as well as presentations from listed Life Science companies take on their late-stage pipeline.

We are proud to present: Ascelia Pharma, Gubra, BioPorto, Pharma Equity Group and ExpreS2ion Biotechnologies.

Agenda
09.35-09.55 - Introduction
10.00-10.25 - Ascelia Pharma
10.30-10.55 - Gubra
11.00-11.25 - BioPorto
11.30-11.55 - Pharma Equity Group
12.00-12.25 - ExpreS2ion Biotechnologies

Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma, Gubra, BioPorto, Pharma Equity Group and ExpreS2ion Biotechnologies. for a Digital IR/corporate visibility agreement./Mie Halse 14.05.2024 at 13.33.

Stay up to date
Ascelia Pharma
Gubra
BioPorto
Pharma Equity Group
ExpreS2ion Biotech Holding

Recent videos

UPM and Sappi are planning a joint venture in graphic papers
2025-12-04 13:00 UPM-Kymmene
GreenMobility: How far away are driverless cars in Denmark
2025-12-04 11:32 GreenMobility
Systemair, Audiocast, Q2'25/26
2025-12-04 09:00 Systemair
Hafnia – Presentation of the quarterly report for Q3 2025
2025-12-02 11:00 Hafnia
Admicom Capital Markets Day 2025
2025-12-02 09:00 Admicom
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.